Bioelectronics Corp (BIEL)

[art2426]

>>>And there is no longer an ActiPatch patent upon which to infringe. They all expired due to non-payment of fees.<<<


YEP, we can assume no money to pay the fees. Just another 'no money' excuse to answer stockholder concerns of "why"?
Like why no more quarterly reports?
Like why no advertising?
Like why no more official PR's instead of facebook and instagrams that stockholders need to find for themselves?
Like why no more sales rep?

Probably the worse excuse to give stockholders is "we don't have the funds". How is all that not very concerning for investors? Especially when you stand to lose probably the most important asset you have in those patents, if you ever want to sell the business. Without it you have nothing to sell.